Literature DB >> 2423403

Early predictors of neurodevelopmental outcome of very low-birthweight infants at three years.

G Ross, E Lipper, P A Auld.   

Abstract

Seventy-nine premature infants weighting less than 1501 g at birth but appropriate for gestational age underwent a neurodevelopmental examination at one, three, six, nine and 12 months post-term, and a standard neurological examination and the Stanford-Binet Intelligence Scale at three to four years of age. Children were classified as normal, suspect or abnormal on the three-year neurological examination, on the IQ test, and on composite neurodevelopmental outcome at age three years. Results showed that items from both the nine- and 12-month neurodevelopmental examinations correctly classified about 80 per cent of the children as to composite outcome at three years. In addition, the 12-month examination enabled correct prediction for 89 per cent of the children as to neurological outcome and for 82 per cent as to IQ. Neurodevelopmental examination of high-risk infants in the last quarter of the first year of life (post-term) should assist pediatricians in predicting which children will be normal and which will require early intervention.

Entities:  

Mesh:

Year:  1986        PMID: 2423403     DOI: 10.1111/j.1469-8749.1986.tb03851.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  The long-term prognosis of pre-term infants: conceptual, methodological, and ethical issues.

Authors:  Linda S Siegel
Journal:  Hum Nat       Date:  1994

2.  Qualitative changes in general movements and their prognostic value in preterm infants.

Authors:  J J Geerdink; B Hopkins
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

Review 3.  Neurodevelopmental outcome of hydrocephalus following intra-/periventricular hemorrhage in preterm infants: short- and long-term results.

Authors:  B Resch; A Gedermann; U Maurer; E Ritschl; W Müller
Journal:  Childs Nerv Syst       Date:  1996-01       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.